The Hematologist

banner image

Ask the Hematologists

Drs. Hillard Lazarus and Per Ljungman discuss the optimal approach to prevent CMV infection in patients undergoing AHCT in 2018.

Read more
banner image

Surround and Protect!

Dr. Kim studies the association between high macrophage count and poor response to traditional chemotherapy, but remarkable response to PD-L1-directed immunotherapy in relapsed/refractory cHL.

Read more
banner image


Drs. Theresa Coetzer and Eduardo Rego discuss ASH global initiatives and the impact they have on international hematologists and their patients.

Listen here
Current Issue Static Feature

Current Issue

March/April 2018
Volume 15, Issue 2

Read current issue

President's Column

Presidents Column - Kenneth AndersonHead of Hematology Section and Director of Comprehensive Thalassemia Program, A. Watson and Sarah Armour Endowed Chair for Childhood Cancer and Blood Disorders, Ann and Robert H. Lurie Children's Hospital; Associate Director of Equity and Minority Health, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
In a Global State of Mind
March 6, 2018

Dr. Thompson provides an overview of ASH global initiatives and the Society's global reach.

View all president's column articles

  • ASH Applauds the Sickle Cell Disease Surveillance, Prevention, and Treatment Act of 2018
    March 09, 2018

    Senators Tim Scott (R-SC) and Cory Booker (D-NJ) introduced the Sickle Cell Disease Surveillance, Prevention, and Treatment Act of 2018.

  • Update on Tax Reform
    December 20, 2017

    On December 20, the House of Representatives and the Senate voted to approve H.R. 1, tax reform legislation. Select members of each chamber came together to resolve disagreements between the two versions passed by the House and Senate.

  • 2017 Action of the Affordable Care Act
    December 05, 2017

    Congress spent much of 2017 focused on the repeal and replace of the Affordable Care Act (ACA). Included is a summary of Congress and the Administration’s actions on repeal and replace of the ACA that occurred in 2017.

  • 2017 ASH Advocacy Activities
    November 29, 2017

    ASH continues to increase its efforts to expand and enhance the Society’s reach. NIH funding, efforts to ensure patient access to drugs, and sickle cell disease were top priorities on ASH’s advocacy agenda in 2017.

View all Policy News